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ABSTRACT
CpG methylation in mammalian DNA is known to
interfere with gene expression by inhibiting the
binding of transactivators to their cognate
sequence motifs or recruiting proteins involved in
gene repression. An Epstein–Barr virus-encoded
transcription factor, Zta, was the first example of a
sequence-specific transcription factor that prefer-
entially recognizes and selectively binds DNA
sequence motifs with methylated CpG residues,
reverses epigenetic silencing and activates gene
transcription. The DNA binding domain of Zta is
homologous to c-Fos, a member of the cellular
AP-1 (activator protein 1) transcription factor
family, which regulates cell proliferation and
survival, apoptosis, transformation and oncogen-
esis. We have identified a novel AP-1 binding site
termed meAP-1, which contains a CpG dinucleotide.
If methylated, meAP-1 sites are preferentially bound
by the AP-1 heterodimer c-Jun/c-Fos in vitro and in
cellular chromatin in vivo. In activated human
primary B cells, c-Jun/c-Fos locates to these
methylated elements in promoter regions of tran-
scriptionally activated genes. Reminiscent of the
viral Zta protein, c-Jun/c-Fos is the first identified
cellular member of the AP-1 family of transacti-
vators that can induce expression of genes with
methylated, hence repressed promoters, reversing
epigenetic silencing.
INTRODUCTION
AP-1 (activator protein 1) is a family of transcription
factors involved in cell proliferation and survival, apop-
tosis, transformation and oncogenesis. AP-1 proteins
contain a basic leucine zipper (bZIP) domain and belong
to three different subfamilies: Jun (c-Jun, JunB and
JunD), Fos (c-Fos, FosB, Fra-1 and Fra-2) and ATF
(activating transcription factor: ATFa, ATF2, ATF3,
ATF4 and B-ATF). To bind to DNA, members of the
different subfamilies need to form dimers, which show
different affinities for two classes of DNA sequences.
They are 12-O-Tetradecanoylphorbol-12-Acetate (TPA)
response elements (TRE) and cyclic adenosine
monophosphate (cAMP) response elements (CRE),
which encompass the consensus sequences 50-TGAC/
GTCA-30 and 50-TGACGTCA-30, respectively. In
general, Jun/Jun and Jun/Fos dimers show a higher
affinity for TRE sites, whereas Jun/ATF and Fos/ATF
dimers preferentially bind to CRE sites (1).
Different cellular signaling pathways, referred to as
mitogen-activated protein kinase (MAPK) cascades,
regulate both the expression and post-translational modi-
fications of AP-1 proteins. The prototypic AP-1 member is
the c-Jun/c-Fos heterodimer, and both proteins are
regulated by MAPK pathways (2). Many different extra-
cellular stimuli, such as growth factors and cytokines,
trigger the MAPK cascades consisting of a hierarchy of
sequential kinases that finally activate the three main
MAP kinases called JNK, ERK and p38. These proteins
can phosphorylate different transcription factors, which in
turn activate the expression of c-jun and c-fos genes. Once
expressed, the c-Jun and c-Fos proteins form dimers
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and bind to their target DNA sequence motifs, but they
also need to be phosphorylated, a modification that can be
introduced by MAPKs as well, to activate transcription of
target genes with AP-1 binding sites in their promoters (1).
In eukaryotic cells, transcriptional activation depends
on chromatin structure, nucleosomal occupancy, histone
modifications and DNA methylation, which are diverse
processes that play important roles in transcriptional regu-
lation. Transcriptionally repressed heterochromatin is
characterized by the frequent occurrence of cytosine nu-
cleotides with a methyl group at the 50 position of the
cytosine pyrimidine ring followed by guanine nucleotides,
termed CpG. DNA methylation affects the transcription
of genes in two ways. First, methylation of DNA itself
may physically impede the binding of transcriptional
proteins to promoters and, second, methylated DNA
may be bound by proteins known as methyl-CpG-
binding domain proteins (MBDs). MBD proteins then
recruit additional proteins to the locus, such as histone
deacetylases and other chromatin remodeling proteins
that modify histones and promote the formation of
compact, inactive and silenced chromatin, leading to
gene repression (3).
CpG methylation is indicative of transcriptional repres-
sion, but we and others have recently found that a viral
transcription (Zta) factor preferentially binds to CpG-
methylated DNA sequence motifs activating epigenetically
repressed viral promoters (4,5). The Zta protein (also
termed BZLF1, ZEBRA, Z or EB1) is the major immedi-
ate early transactivator of a human herpes virus, Epstein–
Barr virus (EBV). Zta’s bZIP domain is highly homolo-
gous to cellular AP-1 members, especially c-Fos (6). In a
systematic approach, we mapped all Zta response
elements (ZREs) within promoters of viral genes and
identified two classes of ZREs, which are characterized
by two distinct binding motifs. One class encompasses
nearly all ZREs, which bind to an AP-1-related DNA
motif. The second class encompasses ZREs with a CpG
motif. Zta binds to the majority of these ZREs only when
the cytosine in the CG dinucleotide carries a 50-methyl
group. Consequently, these sites were termed meZREs.
Zta binds to meZRE motifs and dramatically induces
viral gene expression but in a methylation-dependent
fashion (5). This exceptional feature is essential for this
herpes virus to escape from its latent phase of infection,
which is governed by transcriptional silencing of the
majority of viral genes including extensive and widespread
CpG methylation of viral DNA (7).
To our knowledge, only two reports indicate that
cellular transcription factors also can target methylated
DNA sequence motifs supporting gene transcription in
metazoan cells in vivo. Sp1/Sp3 binding is not commonly
impaired by CpG methylation (8) but rather enhanced in
the context of a tissue-specific promoter (9). When
methylated, cAMP response elements (CRE) or composite
CRE and C/EBP sequence elements generate novel
binding sites for C/EBPa activating certain promoters
(10), which is an unexpected finding (11).
Herpes viruses acquire cellular genes through recombin-
ation with host cell DNA. Cellular genes adopted and
further modified by this class of viruses regulate apoptosis,
control the cell cycle of infected cells and block host
immune responses (12). Very likely, the viral BZLF1 gene
encoding Zta is derived from a cellular member of the AP-1
family (6), has evolved to act as the critical immediate-early
gene of EBV to allow exit from latently infected cells (13)
and activates resting primary human B cells, the target of
EBV infection (14). As described earlier in the text, the
bZIP domain of Zta is highly conserved when compared
with bZIP domains of AP-1members andmediates binding
to CpG-methylated DNA sequence motifs. Zta might have
inherited this peculiar feature from cellular AP-1 members
that could target and activate repressed cellular promoters
encompassing CpG-methylated DNA as well. This hypoth-
esis would substantiate a previously unknown type of gene
regulation and constitute a new example of a cellular tran-
scription factor capable of activating gene expression from




HEK293, Raji and K562 cells were maintained in RPMI
1640 medium with 10% fetal calf serum (FCS), 1% peni-
cillin–streptomycin and 1% sodium pyruvate at 37C and
5% CO2. Wi-38 cells were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) medium with 10%
FCS, 1% penicillin–streptomycin and 1% non-essential
amino acids at 37C and 5% CO2. Adenoid B cells were
maintained in RPMI 1640 medium supplemented with
10% FCS, 100 mg/ml streptomycin, 100U/ml penicillin,
100 nM sodium selenite and 1 mg/ml cyclosporin A at
37C and 5% CO2. For cellular activation, B cells were
cultured on irradiated CD40L feeder cells in the presence
of 2 ng/ml IL-4 for 5 days as described (15).
Plasmids
The wild-type maxi-EBV plasmid (p2089) contains the
complete genome of the EBV prototype B95.8 strain and
has been described (16). The DNA binding and dimeriza-
tion domains of human c-Jun and c-Fos (amino acid
residues 123–331 and 1–206, respectively), separated by
a flexible linker (SG4)5 (17), were cloned downstream of
the coding region of enhanced green fluorescence protein
(eGFP) in pEGFP-C1 (Clontech), to generate the expres-
sion plasmid p4271, or downstream of the tandem StrepII/
FLAG-tag (18) to yield the plasmid p4548. The plasmid
expressing VP16:c-jun/c-fos (p4316) was generated by
replacing the gfp gene by the VP16 transactivation
domain (TAD) of the VP16 protein from HSV-1 (amino
acid residues 404–490). Luciferase plasmids were con-
structed by inserting pentamers of single meAP-1 sites
into a basic luciferase reporter plasmid with a minimal
EF1a promoter. The plasmid backbone of this reporter
plasmid is free of CpGs (19).
DNA transfection
Transfection of DNA into HEK293 cells was performed
using polyethylenimine (Sigma-Aldrich) as previously
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described (14). For protein extracts, 1 107 cells per 130-
mm dish were seeded the day before transfection. Each
plate was transfected with 30 mg of plasmid DNA. For
reporter assays, 5 105 HEK293 cells were seeded into
6-well plates the day before transfection. Each well was
cotransfected with 0.5mg of reporter plasmid together with
1 mg of transactivator and 0.01mg of DNA of a renilla-
expressing plasmid as an internal control for data
normalization.
In vitro DNA methylation
CpG methylation in vitro was performed with the de novo
methyltransferase M.SssI and S-adenosyl methionine as
described (5,20).
In vitro immunoprecipitation assays with GFP:c-Jun/c-Fos
For the in vitro pull-down assays, the plasmid p4271
encoding gfp:c-jun/c-fos was transiently transfected into
HEK293 cells. Nuclear extracts containing the GFP:c-
Jun/c-Fos protein were used in in vitro immunopre-
cipitation assays with Escherichia coli-derived genomic
EBV DNA as described (5).
Recombinant adenovirus generation and cell infection
The adenoviral expression vector was created using
the Gateway Recombination Cloning Technology
(Invitrogen). Shortly, the gfp:c-jun/c-fos coding region
was amplified by polymerase chain reaction (PCR),
introduced in the PCR8/GW/TOPO vector, and then
transferred to the pDEST12.2 vector. The latter plasmid
was used to recombine the gfp:c-jun/c-fos cassette into the
adenoviral vector pCAGAdDu-GFP (provided by Dr
Vigo Heissmeyer).
Stable transfection and establishment of cell lines
Five micrograms of p4271 DNA was transfected into
5 106 Raji cells by electroporation in 250 ml medium at
230V and 975 mF using a Biorad electroporation appar-
atus in 4-mm cuvettes. Immediately after electroporation,
400 ml of FCS was added to the cells, which were
transferred to a flask containing 5ml of cell culture
medium. Cells were incubated at 37C and 5% CO2 for
one day. The cells were plated into 96-well plates in 200 ml
of cell culture medium/well, supplemented with puro-
mycin (1.2 mg/ml) until resistant cells grew out, which
were further cultivated under selective pressure.
Native chromatin immunoprecipitations
A total of 5 107 Raji cells expressing the GFP:c-Jun/
c-Fos protein were used for chromatin immunopre-
cipitation (ChIP) experiments, which were performed as
described previously (5).
Electromobility shift assays
Electromobility shift assays (EMSAs) were performed as
described previously [Bergbauer et al. (5)].
Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assays (ELISAs) were
performed with purified protein from HEK293 cells
transiently transfected with Strep/FLAG:c-Jun/c-Fos
(p4548). Two days post-transfection, cells from three
130-mm dishes were pooled and lysed in 2ml of RIPA-
buffer (50mM Tris, 150mM NaCl, 1% NP40, 0.5%
DOC, 0.1% SDS, pH 8.0). Cell lysates were sonicated
and Strep/FLAG:c-Jun/c-Fos was affinity purified with
Strep-Tactin sepharose (iba-biotagnology). Strep/
FLAG:c-Jun/c-Fos was eluted in 500 ml of Strep elution
buffer. Purified Strep/FLAG:c-Jun/c-Fos protein was
coated on a 96-well ELISA plate at 100 nM in phos-
phate-buffered saline at 4C overnight. Cy5-labeled oligo-
nucleotides were provided by Metabion. After washing
and blocking with 5% bovine serum albumin, 100 ml of
serial dilutions of annealed double-stranded Cy5-labeled
oligos (in 20mM Hepes, 75mM NaCl, 1mM DTT, 1%
glycerin, 2mM MgCl2, 0.01mg/ml bovine serum albumin
and a 20molar excess of polydIdC) were then added and
incubated for 2 h at room temperature. Unbound oligo
was removed with repeated washes in phosphate-
buffered saline. Finally, the Cy5 levels/well were
measured in the phosphoimager (FLA 5100, Fuji). The
obtained data were fit to the Hill equation with single
site-specific binding using the Prism 5 software to calculate
the dissociation constant.
Luciferase reporter assays
Forty-eight hours post-transfection, the HEK293 cells
were analyzed with the Dual-Luciferase Reporter Assay
System (Promega). Luciferase activity was measured in a
96-well microplate luminometer (Victor2, Wallac).
Bisulfite sequencing
Bisulfite modification was done using the EpiTect Bisulfite
Kit (Qiagen), and the regions of interest were amplified by
suitably designed PCR primer pairs. Primer sequences are
available on request.
Library construction
Sequence libraries were constructed with paired-end DNA
sample preparation kits (Illumina) according to the manu-
facturer’s recommendations with minor modifications and
as described previously (5). In vitro immunoprecipitations
with non–CpG-methylated and fully CpG-methylated
EBV DNAs were converted into the libraries
‘4271.unmethylated’ and ‘4271.methylated’, respectively.
DNA obtained with ChIP of Raji cell chromatin was con-
verted into the library ‘4427.Raji’. Wi-38 DNA used for
ChIP and ChIP DNA were converted into the libraries
‘4673.Wi38.Input’ and ‘4673.Wi38.ChIP’, respectively.
Read mapping
Sequencing reactions were performed on an Illumina
Genome Analyzer IIx or Illumina HiSeq 2000 machines.
We generated 32 million and 31 million 36-bp single-
end reads for libraries ‘4271.unmethylated’ and
‘4271.methylated’, respectively, 50 million 36-bp single-
end reads for ‘4427.Raji’ and 50 and 47 million 100-bp
pair-end reads for the ‘4673.Wi38.Input’ and
‘4673.Wi38.ChIP’ samples, respectively. Read mapping
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to the reference sequence and subsequent assembly was
performed using the resequencing software Burrows-
Wheeler Alignment (BWA) (v0.7.1; 21). We used a com-
bination of the recombinant EBV strain 2089 (16) and the
bovine genome (build bosTau4) as reference sequences for
the two libraries ‘4271.unmethylated’ and ‘4271.
methylated’. Calf thymus DNA was used as an unspecific
competitor in the in vitro immunoprecipitation assays with
GFP:c-Jun/c-Fos. The reference sequence for the in vivo
samples ‘4427.Raji’, ‘4673.Wi38.Input’ and ‘4673.
Wi38.ChIP’ was the human reference sequence hg19.
Transcription factor binding site detection
Genomic regions with a read depth above background
level are considered as regions containing transcription
factor binding sites. We used two different programs,
Site Identification from Short Sequence Reads (SISSRs)
(22) and QuEST (23), to identify these regions.
Transcription factor binding sites are typically shorter
than the sequenced DNA fragments. Binding sites
for the sample libraries ‘4271.unmethylated’ and
‘4271.methylated’ were determined using SISSRs
standard parameters, except for E (min number of direc-
tional reads), which was set to 3200 for the library
‘4271.unmethylated’ and to 1600 for ‘4271.methylated’,
and F (average length of DNA fragments), which was
set to 200 in both cases. Binding sites for the sample
‘4427.Raji’ were inferred using the default QuEST param-
eters, except for kernel density estimator and read count
threshold (th), which were set to 30 and 160, respectively.
In the case of the sample ‘4673.Wi38.ChIP’, it was
analyzed by SISSRs with the results from‘4673.
Wi38.Input’ as background file and setting th at 220. To
identify consensus motifs within the discovered binding
sites, the sequences containing possible binding sites
were extracted and used as input for the motif finding
algorithm Multiple EM for Motif Elicitation (MEME)
(24).
ChIPs with an a-c-Jun antibody
ChIP experiments were conducted following standard
protocols. Chromatin was cross-linked for 10min
at room temperature and incubated with the antibody
a-c-Jun (sc-44, Santa Cruz Biotechnology).
Quantitative real time PCR
Quantitative real time PCR (qRT-PCR) analysis was per-
formed with a LightCycler 480 II instrument (Roche),
with software version 1.5.0 SP4, according to the manu-
facturer’s instructions. Amplifications were monitored
with the LightCycler FastStart reaction mix (SYBR
green I; Roche). The amplification of PCR products was
terminated after 45 cycles. The following touchdown PCR
protocol was used: (i) initial denaturation at 95 for 10min
and (ii) 45 cycles of 95 (2 s), 65–62 (0.6 decrement in
annealing temperature/cycle; 10 s), 72 (10 s). For all
primer pairs, a standard curve from serial dilutions of
the PCR product with known concentration or the input
DNA was assessed. Primer sequences are available on
request.
B cell isolation
Human primary B cells from adenoids were prepared
and naı̈ve B cells were sorted as described previously
(14,25). Anonymized adenoid samples from routine
adenoidectomies were provided by the Department of
Otorhinolaryngology, Klinikum Grosshadern, Ludwig-
Maximilians-University of Munich. The institutional
review board, Ethikkommission of the Klinikum
Grosshadern, approved the study and did not require
prior informed patient consent.
Bioinformatic identification of meAP-1 sites in primary
human B cells
In the reference human genome assembly GRCh37/hg19,
we detectedAP-1 andmeAP-1 binding sites using the search
algorithm Find Individual Motif Occurrences (FIMO) (26)
based on our MEME output motifs. Called sites were
mapped to promoter sequences of RefSeq genes contained
in theUCSCGenome Browser5 kb to+1kb of their tran-
scription start sites (TSS) (27). Predicted meAP-1 binding
site within promoter sequences were further evaluated for
CpG methylation in naı̈ve B cells (28) (C04M7ACXX_XF,
D088DACXX_XF, D08E5ACXX_XF). For further
analysis, we selected only meAP-1 binding sites that show
at least 80% methylation in two of three replicates. To
identify genes upregulated in activated B cells, we used ex-
pression data obtained from unstimulated (GSM907730,
GSM907738, GSM907746) and stimulated (GSM907731,
GSM907739, GSM907747) B cell data sets available on
Gene Expression Omnibus (GSE36975) (29). We selected
transcripts that were significantly expressed in 5 of 6
samples. Transcripts showing significant differential ex-
pression between unstimulated and stimulated B cells
were identified performing a one way ANOVA test using
MATLAB.
RESULTS
c-Jun/c-Fos binding motifs in genomic EBV DNA
We started our search with a synthetic model, which
builds on the entire DNA genome of EBV cloned in
E. coli as a single plasmid (16). This DNA is large
(180 kb), GC-rich (60%), free of methylated cytosine nu-
cleotides (which can be easily methylated in vitro),
contains 85 genes and diverse promoter elements and
has been used previously for the analysis of Zta’s DNA
binding characteristics (5). We predicted that the DNA’s
complexity and size is suitable to identify putative DNA
motifs, which are targeted by AP-1 if methylated. The
second component in our model is a single-chain c-Jun/
c-Fos protein designed to ensure the formation of a single,
defined AP-1 heterodimer unaffected by other proteins
that complex with either c-Jun or c-Fos. Bakiri et al.
(17) showed that similar constructs with the murine se-
quences of c-Jun and c-Fos specifically bind and
transactivate cellular promoters that contain the consen-
sus AP-1 binding site.
We used in vitro pull-down experiments as described (5)
with randomly sheared non–CpG-methylated or fully
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CpG-methylated EBV DNA and a GFP:c-Jun/c-Fos
fusion protein purified from HEK293 cells.
Immunoprecipitation of the fusion protein followed by
deep sequencing of the enriched DNA fragments
provided an extensive coverage of DNA sequences select-
ively bound by the AP-1 heterodimer (Supplementary
Figure S1). A comparison of fully CpG-methylated
versus non–methylated-DNA identified several regions
preferentially bound by c-Jun/c-Fos if CpG-methylated
(Supplementary Figure S1, bottom), three of which were
located at EBV promoters: BFLF2, BBLF4 and BALF1
(Supplementary Figure S2A). Algorithms suitable to
identify sequences of potential binding sites readily
found the known palindromic AP-1 consensus binding
site 50-TGACTCA-30 (Figure 1) in samples of
unmethylated as well as methylated DNA, confirming
the validity of our approach. Putative AP-1 binding
motifs identified in CpG-methylated DNA were grouped
according to whether they encompassed CpG pairs or not.
The reanalysis revealed a second, novel motif, 50-TGACG/
TCG-30, which is closely related to the consensus AP-1 but
may contain up to two CpG dinucleotides. We termed this
motif ‘meAP-1’ in analogy to meZRE motifs bound by
Zta (5). Lists of the identified AP-1 binding sites are
provided in Supplementary Tables S1–S3.
To determine whether the biochemically identified
meAP-1 sites in EBV DNA are also bound by c-Jun/
c-Fos in cells in vivo, we engineered a derivative of the
latently EBV-infected cell line Raji with a constitutively
expressed GFP:c-Jun/c-Fos chimera. ChIP followed by
deep sequencing analysis (ChIP-seq) of DNA fragments
specifically bound to GFP:c-Jun/c-Fos protein was per-
formed, mapped to the EBV genome and analyzed
bioinformatically in conjunction with methylation data
(7). Confirming our results in vitro, the analyzed pro-
moters in Raji cells were only enriched if the meAP-1
sites were highly CpG-methylated (Supplementary
Figure S2).
c-Jun/c-Fos binds CpG-methylated meAP-1 sites with
high affinity mediating transcriptional activation
The different meAP-1 motifs identified in the EBV genome
may contain up to two CpG pairs (Figure 1), but the three
more prominent meAP-1 sites (Supplementary Figure S1),
located in three EBV promoters, encompass the sequence
50-TGACTCG-30 with one CpG pair, only (Figure 2A).
We addressed this uncertainty together with the question
of whether 50-methylcytosine residues present in the top,
bottom or both strands of the meAP-1 DNA sequence
affect the affinity of c-Jun/c-Fos binding to DNA.
Unmethylated or CpG-methylated synthetic oligo-
nucleotides containing the meAP-1 binding sites in the
BBLF4, BFLF2 and BALF1 promoters (Figure 2A) and
three promoters identified later in ChIP-seq experiments
with Raji cell chromatin (Supplementary Figure S3) were
analyzed in EMSAs. As shown in Figure 2B, c-Jun/c-Fos
bound almost exclusively to the CpG-methylated meAP-1
motif 50-TGACTCG-30 that contains a single CpG pair,
but methylation of a CpG pair in a more central position
of the motif decreased the binding of c-Jun/c-Fos
(Supplementary Figure S3B). Therefore, we concentrated
our analysis on meAP-1 binding sites with a CpG pair at
the distal position. The consensus meAP-1 site consists of
the sequence motif 50-TGACTCG-30, and only the methyl
group in 50 position of the cytosine in the bottom strand is
necessary for the methylation-specific binding of c-Jun/c-
Fos to DNA (Figure 2C).
To quantify DNA binding, the apparent dissociation
constants (KD) of c-Jun/c-Fos were measured with
unmethylated or methylated meAP-1 binding sites. The
KD values of BBLF4, BALF1 and BFLF2 meAP-1 sites
were lower by a factor of 38.7, 10.0 and 171, respectively,
if methylated, indicating that the presence of
50-methylcytosine increases the binding affinity of c-Jun/
c-Fos to DNA (Figure 2D). The consensus AP-1 binding
site from the human ‘collagenase’ promoter (TREcollag)
with a published KD for c-Jun/c-Fos of 10.8 nM (30) was
used as a positive control.
The transactivation potential of the c-Jun/c-Fos
heterodimer was investigated in luciferase reporter
assays. Reporter plasmids containing pentamers of the
three selected meAP-1 sites were transiently transfected
into HEK293 cells together with an expression plasmid
encoding VP16:c-Jun/c-Fos, in which the VP16
transactivator domain was fused to the single-chain AP-
1 heterodimer. VP16:c-Jun/c-Fos induced the CpG-
methylated reporter plasmids by a factor of 2–5 as
compared with their non-methylated controls (Figure 2E).
The human genome contains meAP-1 binding sites
Two different cell lines were used to identify AP-1 and
meAP-1 binding sites in vivo, the Burkitt lymphoma B-
cell line Raji and the human fibroblast cell line Wi-38.
As explained earlier in the text, a Raji cell line expressing
the GFP:c-Jun/c-Fos chimera was used in ChIP-seq
AP-1 (35 sites) meAP-1 (9 sites)
no CpG CpG
AP-1 (61 sites) (44 sites)
unmethylated methylated
























Figure 1. Bioinformatic identification of c-Jun/c-Fos binding motifs in
the EBV genome. Deep sequencing data were analyzed with the SISSRs
algorithms for putative stretches of DNA, which c-Jun/c-Fos binds.
The output files of SISSRs were used as training sets for MEME,
which identifies gapless, local and multiple sequence motifs. A total
of 61 motifs were identified in the DNA free of CpG methylation
and 44 motifs were identified in the fully CpG-methylated EBV
DNA. The identified motifs in methylated DNA were selected at the
level of the SISSRs training set data and grouped into motifs with and
without CpG dinucleotides followed by MEME analysis.
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Figure 2. The c-Jun/c-Fos binds preferentially to and activates gene transcription through CpG-methylated meAP-1 motifs. (A) Oligonucleotides
containing meAP-1 binding sites identified in the viral BBLF4, BALF1 and BFLF2 promoters. The TREcollag oligo containing a consensus AP-1
binding site was used as a control for the KD measurements. The meAP-1 sites and AP-1 site are indicated in bold capital letters, and the CpG pairs
within the meAP-1 sites are underlined. (B) Preferential binding of c-Jun/c-Fos to methylated meAP-1 sites from the EBV genome. EMSAs were
performed with affinity-purified GFP-tagged c-Jun/c-Fos fusion protein transiently expressed in HEK293 cells. Supershifts with a GFP antibody
confirmed the identity of the protein–DNA complexes. EMSAs of typical experiments are shown as examples. (C) Only one methyl group is
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(continued)
experiments. In a second experimental setting, serum-
starved Wi-38 cells were infected with a GFP:c-Jun/
c-Fos-expressing adenovirus. Chromatin from Wi-38
(two days post infection) and Raji cells was prepared,
immunoprecipitated with an a-GFP antibody to enrich
DNA fragments specifically bound by GFP:c-Jun/c-Fos
protein and analyzed with next-generation sequencing
(Figure 3).
In accordance with our first functional analysis shown
in Supplementary Figure S3B and discussed earlier in the
text, we adjusted the bioinformatic parameters and refined
the characteristics of the two AP-1 motifs found previ-
ously: consensus AP-1 motifs lacking a CpG dinucleotide
and putative meAP-1 motifs with a single distal CpG pair
in positions six and seven (Figure 3A and B). The two
predominant motifs revealed in both cellular models
confirm the known AP-1 consensus (50-TGACTCA-30)
and identified an infrequent second meAP-1 motif
(50-TGAC/GTCG-30) (Figure 3A and B). Supplementary
Tables S4 through S7 provide the location of the AP-1 and
meAP-1 sites in both cell types.
The majority of all consensus AP-1 sites are located in
intergenic regions (31,32) with no assigned functions. To
concentrate our further analysis on meAP-1 sites in prox-
imity of promoter elements, meAP-1 sites located within
5 kb upstream of annotated TSS were considered only if
no other conventional AP-1 was located within a window
of ±1kb. Only a small number of cellular genes fulfilled
our criteria. From ChIP-seq experiments of Raji cells, we
included the promoters of three genes in our study, PTK6,
P2RY5 and SUV39H1. In Wi-38 cells, we concentrated on
two genes, CBR3 and LRRTM2. A positive control, the
collagenase promoter MMP1 containing two AP-1
binding sites (33) was also included.
Visualization of the coverage of these promoters after
ChIP-seq analysis indicated that they are differentially
bound by c-Jun/c-Fos in the two cell types (Figure 3C),
suggesting that the extent of cytosine methylation might
also differ. Bisulfite sequencing of the five promoters
revealed only one promoter element, P2RY5, that was
fully CpG-methylated in both cell lines, but CpG pairs
in other promoters with meAP-1 sites differed in a cell
type-specific manner (Supplementary Figure S4).
50-methylcytosine-dependent binding of c-Jun/c-Fos to
meAP-1 sites in the human genome induces
transcriptional activation
Only 5% of meAP-1 sites identified in both cell types are
located in putative promoter regions, and therefore
presumably involved in directly regulating gene expres-
sion. Three candidate meAP-1 motifs with no AP-1 con-
sensus binding sites in their close proximity were analyzed
further: the meAP-1 sites in the PTK6, P2RY5 and
SUV39H1 promoters (Figure 4). As shown in Figure 4B,
c-Jun/c-Fos bound almost exclusively to the CpG-
methylated meAP-1 motif. In ELISAs, the apparent dis-
sociation constants (KD) of PTK6 and P2RY5 meAP-1
sites could only be determined with methylated oligo-
nucleotides because KD values of the unmethylated
probes were too high to be estimated (Figure 4C). The
KD for the SUV39H1 meAP-1 site could not be
calculated, but the results confirm that the binding
affinity is higher when the meAP-1 site is methylated
(Figure 4B and C). These results indicate that the
presence of 50-methylcytosine favors the binding of
c-Jun/c-Fos to the meAP-1 sequences identified in the
human genome.
The ability of c-Jun/c-Fos to transactivate gene tran-
scription through the binding to the methylated meAP-1
sites from the human genome was tested in reporter
assays. Reporter plasmids containing pentamers of
selected meAP-1 sites in the human promoters were
cotransfected with an expression plasmid encoding the
transactivator VP16:c-Jun/c-Fos or a negative control
DNA. Luciferase activities with CpG-methylated
reporter plasmids were significantly higher as compared
with unmethylated reporter plasmid DNAs (2.0–2.7-fold,
Figure 4D).
Promoters with methylated meAP-1 sites are bound by
c-Jun/c-Fos in vivo
So far our studies were based on the ectopic expression of
artificial c-Jun/c-Fos dimers to identify potential meAP-1
sites in cellular DNA. In contrast, Raha et al. (31) mapped
the location of endogenous c-Jun and c-Fos protein in two
sets of ChIP-seq experiments and identified >40 000
binding sites in the established human myeloblastic cell
line K562. To correlate their findings and ours, we per-
formed ChIP assays in this cell line with a c-Jun specific
antibody and investigated by quantitative PCR analysis
the enrichment of the five previously identified promoter
elements PTK6, P2RY5, SUV39H1, CBR3 and LRRTM2
along with negative and positive control regions (34). As
shown in Supplementary Figure S5, the previously
identified five promoter elements, which contain only
meAP-1 but no consensus AP-1 sites, were enriched at
levels similar to or exceeding those of the positive
controls in K562 chromatin indicating that endogenous
Figure 2. Continued
responsible for the binding of c-Jun/c-Fos to methylated DNA. The meAP-1 and AP-1 binding sites contained in the oligonucleotide used in EMSAs
are shown; the asterisks represent a 50-methylcytosine residue. EMSAs using BBLF4 and TREcollag oligonucleotides with the sites depicted in the
left panel and GFP:c-Jun/c-Fos-purified protein are shown. One representative experiment out of three is provided. (D) Determination of the
apparent KD of c-Jun/c-Fos bound to meAP-1. ELISAs were performed with affinity-purified Strep/FLAG-tagged c-Jun/c-Fos fusion protein
transiently expressed in HEK293 cells. Serial dilutions of Cy5 oligonucleotides were used to determine the KD values. The obtained data were
fitted to the Hill equation with one site-specific binding to determine the dissociation constants, which are indicated. Each data point indicates the
mean and standard deviation of three independent experiments. (E) Functional identification of single meAP-1 binding sites. Pentamers of single
meAP-1 sites present in the promoters of BBLF4, BALF1 and BFLF2 EBV genes as in (A) were introduced into a basic luciferase reporter plasmid
with a minimal EF1a promoter and free of CpG dinucleotides. Unmethylated and fully CpG-methylated reporter constructs were analyzed in the
presence or absence of a cotransfected VP16:c-Jun/c-Fos expression plasmid. Each experiment was performed three times and the means and
standard deviations are depicted.
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Figure 3. Identification of AP-1 binding motifs in the human genome. Identification of c-Jun/c-Fos binding motifs in Raji (A) and Wi-38 (B) cells. The
samples used for deep sequencing were prepared as indicated. Data obtained from Raji and Wi-38 cell ChIPs were analyzed with the algorithms QuEST
and SISSRs, respectively. MEME analysis was conducted as described in detail in the legend of Figure 1. In chromatin of Raji and Wi-38 cells, 9232 and
6547 motifs, respectively, were discovered, which were subsequently split into two groups. One group contains all motifs identified with the aid of the
MEME algorithm harboring a CpG pair in positions 6 and 7 of the consensus motif. In all, 80 and 48 motifs were identified in Raji and Wi-38 cells,
respectively, termed meAP-1. The remaining motifs were reanalyzed by MEME, which identified 7017 and 6499 sites that correspond to the known
consensus AP-1 site lacking a CpG dinucleotide. (C) Visualization of selected human promoters with meAP-1 sites that bind c-Jun/c-Fos in vivo. The
‘collagenase’ (MMP1) promoter served as a positive control. Depicted is the read depth (coverage) at single base pair resolution (y-axis). The boxes
indicate the position of the transcripts. Genomic coordinates correspond to the human genome assembly GRCh37/hg19.



























































prot       -    +     -   +
unme me 
-   +     -   +
SUV39H1 PTK6 P2RY5 
unme me unme me 
-   +     -   +
5xSUV39H1 5xPTK6 5xP2RY5 
Figure 4. Functional analysis of human meAP-1 sites. (A) Oligonucleotides containing meAP-1 binding sites of the PTK6, P2RY5 and SUV39H1
promoters. The meAP-1 sites are indicated in bold capital letters and the CpG pairs within the meAP-1 sites are underlined. (B) EMSAs showing the
preferential binding of c-Jun/c-Fos to the CpG-methylated meAP-1 sites of the PTK6, P2RY5 and SUV39H1 promoters. EMSAs were performed
with affinity-purified GFP-tagged c-Jun/c-Fos fusion protein transiently expressed in HEK293 cells. EMSAs of typical experiments are shown.
(C) Determination of the apparent KD of c-Jun/c-Fos bound to meAP-1. ELISAs were performed with affinity-purified Strep/FLAG-tagged c-
Jun/c-Fos fusion protein transiently expressed in HEK293 cells. Serial dilutions of Cy5 oligonucleotides were used to determine the KD values. The
data were fitted to the Hill equation with one site-specific binding to determine the dissociation constants, which are indicated. Each data point
indicates the mean and standard deviation of three independent experiments. (D) The c-Jun/c-Fos activation of promoters with meAP-1 binding sites
is increased on CpG methylation. Pentamers of short oligonucleotides shown in (A), which contain the meAP-1 sites present in the promoters of the
human PTK6, P2RY5 and SUV39H1 genes were introduced into a basic luciferase reporter plasmid as described in Figure 2E. Unmethylated and
fully CpG-methylated reporter constructs were analyzed in the presence or absence of a cotransfected VP16:c-Jun/c-Fos expression plasmid. Each
experiment was performed three times and means and standard deviations are depicted.
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AP-1 can target meAP-1 sites in the context of cellular
chromatin.
Next, we analyzed the state of CpG methylation in
K562 cell DNA by bisulfite sequencing. The repetitive
meAP-1 site within the P2RY5 promoter was fully
methylated (Supplementary Figure S6A) similar to the
situation in Raji and Wi-38 cells (Supplementary Figure
S4A and B). In contrast, two other promoters were only
moderately methylated (Supplementary Figure S6A). If
c-Jun/c-Fos preferentially bound to methylated meAP-1
sites, ChIP experiments with an a-c-Jun antibody
should enrich methylated DNA. A clear enrichment of
methylated CpGs could be detected in the two promoters
of the PTK6 and LRRTM2 genes sequenced after bisulfite
treatment (Supplementary Figure S6B). The single func-
tionally identified meAP-1 binding site in the PTK6
promoter in Raji cell chromatin (Figure 3C) was
enriched 3-fold after ChIP in K562 cells, whereas the re-
maining three potential meAP-1 sites in this promoter,
which were only predicted with the aid of the search algo-
rithm FIMO (26), could not be confirmed in this func-
tional analysis (Supplementary Figure S6B), supporting
the validity of our approach.
In vivo, c-Jun binds meAP-1 motifs in promoters of genes
upregulated in activated primary human B cells
Our detailed characterization of the newly discovered
meAP-1 motif provided evidence that c-Jun/c-Fos binds
these sequences in vivo. To substantiate our findings, we
wanted to assess if meAP-1 sites are also capable of
conferring transcriptional regulation in the context of
cellular chromatin in a relevant model. AP-1 signaling
cascades play an important role in physiological B cell
activation and differentiation. Comprehensive data sets
are publicly available that address key aspects of the
biology of primary lymphocytes comparing genes
expressed in resting and activated naı̈ve human B cells
(29). In addition, the methylome of naı̈ve human B cells
has been determined recently (28).
Individual AP-1 and meAP1 sites recruit the
heterodimer c-Jun/c-Fos in a highly cell specific manner
as exemplified in Figure 3C comparing Raji B cells and
Wi-38 fibroblasts. Therefore, we turned to the search al-
gorithm FIMO (26) to detect potential AP-1 and meAP-1
binding sites in the reference human genome assembly
GRCh37/hg19 (35) (Supplementary Tables S8 and S9, re-
spectively). Next, we identified those genes in human
DNA that (i) contain potential meAP-1 binding sites
within their promoter regions, from 5 kb to +1kb
relative to the TSS, and (ii) were upregulated by a factor
of two or more comparing activated with resting human
naı̈ve B cells 16 h post induction with CD40 ligand, CpG
stimulation and B cell receptor cross-linking (29). Finally,
we excluded from this list those meAP-1 sites in which the
degree of cytosine methylation of the CpG pair was <80%
in naı̈ve B cells (28). Applying these bioinformatic selec-
tion criteria, we identified 280 genes (Supplementary
Table S10), which were upregulated in activated B cells
(29) and contain methylated meAP-1 sites in their pro-
moters. To focus our attention on the most promising
candidates, we picked 10 genes with presumed functional
meAP-1 sites located within the first 2 kb upstream of the
TSS that are at least 1 kb apart from a consensus AP-1
site, if any.
Table 1 lists the selected genes that fulfill all these
stringent criteria and contain the consensus meAP-1
motif 50-TGACTCG-30. Next, we isolated naı̈ve primary
human B cells, which were activated with CD40-ligand
and IL-4 for 5 days to induce their proliferation and
activate cellular AP-1 pathways. ChIP assays with a
c-Jun-specific antibody were performed and the enrich-
ment of the in silico selected promoter elements was
assessed by quantitative PCR analysis. As shown in
Figure 5, the 10 promoter elements were enriched at
levels similar to those of the positive controls in activated
B cells. The selected meAP-1 sites were confirmed to be











BS-seqd (%) ChIP in
K562 cellse
DCTPP1 14.03 >98 678 n.a. 2.5 >98 3.0
SLAMF1 6.13 100 1698 n.a. 2.6 >90 4.8
UQCRB 3.89 >90 1244 n.a. 3.0 >98 4.0
SCRIB 3.04 >80 1625 n.a. 3.3 >90 3.6
VAT1 2.01 >90 1735 n.a. 2.7 >98 4.2
SAE1 5.79 >90 718 2831 2.3 >98 5.3
PSMC1f 4.69 >80 1418 2532 3.0 100 6.0
>90 929 2.6 n.d. 4.1
ITFG2 3.09 >90 1007 4336 2.7 >90 4.4
LARP4B 2.85 >80 1272 4707 2.6 >98% 3.6
FGR 2.06 >90 744 2004 2.5 >90% 7.0
n.a., not applicable; n.d., not done.
aTranscriptional activation in naı̈ve B cells 16 h post stimulation (29).
bmethylome data from resting naı̈ve B cells (28).
cdata derived from Figure 5, fold enrichment compared with the mean of negative controls.
dBS-seq; bisulfite sequencing; data derived from Supplementary Figure S8.
eData derived from Supplementary Figure S7, fold enrichment compared with the mean of negative controls.
fPSMC1 promoter encompasses two meAP1 and one AP-1 site.
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methylated by analyzing the state of CpG methylation
in genomic DNA of non-activated B cells by bisulfite
sequencing (Table 1 and Supplementary Figure S8).
Supporting our finding in primary B cells, the 10
promoter regions were also bound by c-Jun in the K562
cell line (Supplementary Figure S7).
Table 1 summarizes the original data that led to the in
silico identification of the 10 genes and the experimental
results obtained in this work. Our data indicate that the
predicted meAP-1 binding sites are CpG-methylated and
targeted by c-Jun in activated B cells in vivo, suggesting
that individual meAP-1 sites contribute to transcriptional
activation of highly CpG-methylated, hence epigenetically
repressed genes in naı̈ve B lymphocytes on their activa-
tion. One caveat remains that cannot be addressed experi-
mentally: mitogenic physiological signals in B cell
proliferation and development-like B cell receptor cross-
linking, CD40 engagement and interleukin receptor
signals induce the MAPK cascades leading to AP-1 acti-
vation but also engage additional signaling cascades that
might also act on meAP-1-regulated genes assisting their
transcriptional reactivation (36).
DISCUSSION
The aforementioned results confirm our starting hypoth-
esis and indicate that AP-1 has the capacity to bind a class
of previously unknown discrete DNA sequence motifs
with methylated cytosine residues in vivo. It thus appears
that Zta is not only a closely related member of the large
AP-1 family because it shares a highly conserved DNA
binding domain with c-Fos (6), but also may have
evolved from a predecessor of the AP-1 protein family,
which can specifically make contacts with the 50-methyl
group of cytosine nucleotides. We propose that additional
members of the vast AP-1 family can also bind to
methylated DNA in a sequence-specific manner.
A close inspection of ZRE/meZRE and AP-1/meAP-1
pairs (Figure 6) suggests that they are related but have
evolved differently. (i) In general, nucleotide transitions
(but not transversions) cause the differences within the
ZRE/meZRE and AP-1/meAP-1 pairs (Figure 6A) reflect-
ing only minor differences in the molecular structures of
thymine and 50-methylcytosine (Figure 6B). (ii) The
position of the methylated cytosine in the consensus se-
quences of meZRE and meAP-1 is offset by one nucleotide
(Figure 6A). (iii) The consensus AP-1 motif is almost pal-
indromic but the meAP-1 motif is not, suggesting that
either c-Jun or c-Fos preferentially make contact with
the 50-methylcytosine group. This view is supported by
two detailed reports indicating that c-Fos and c-Jun are
unequal siblings (37,38). Interestingly, Risse et al. (38)
delineated the importance of individual thymine residues
in the AP-1 consensus sequence and found that all
thymines including the two distal positions crucially con-
tribute to DNA–protein interactions.
Zta is the first example of a sequence-specific transcrip-
tion factor, which preferentially recognizes and selectively
binds DNA sequence motifs with methylated CpG
residues and activates gene transcription through these
distinct motifs (4,5). Previously, other mammalian
factors (RXF1, RBP-J, ZBTB4) have been shown to
bind DNA sequences encompassing 50-methylcytosine nu-
cleotides in vitro, only, and no evidence for methylation-
dependent binding of these factors exists in cells in vivo
(39–42). Retrospectively, this failure is not surprising
because consensus meAP-1 motifs are rarely targeted by
c-Jun/c-Fos in cellular chromatin. Accessible and there-
fore functional meAP-1 sites account for <2% of the
45 000 c-Jun/c-Fos binding sites that are predicted in
human genomic DNA (Figure 3A and B; Supplementary
Table S9). This is in contrast to the high number of con-
sensus AP-1 sites predicted in silico (32), which are readily
bound by factors of the AP-1 family in human chromatin
(31,34).
Interestingly, a recent systematic in vitro analysis of a
large panel of transcription factors identified their
frequent binding to sequence motifs with methylated
CpG dinucleotides (43). The search did not identify the
non-canonical meAP-1 motif reported here. Rather, it
revealed distinct and therefore unrelated motifs either
free of CpG dinucleotides or with methylated CpGs
targeted by the same mammalian transcription factor.
This observation is surprising and clearly in contrast
to our findings, which led to the discovery of the
meAP-1 motif, a close relative of the canonical AP-1 site
(Figure 6).
Our results indicate that the 50-methylcytosine residue






















































































Figure 5. In vivo binding of c-Jun/c-Fos to cellular promoters with
meAP-1 sites in activated primary human B cells. After immunopre-
cipitation (ChIP) of chromatin from activated naı̈ve B cells with an a-c-
Jun antibody, the enrichment of the indicated promoter regions was
assayed by quantitative PCR. Shown are the results obtained from
three promoter regions indicated in red that contain conventional pre-
viously identified AP-1 sites (34) and three promoter regions indicated
in black, which were identified in this study and are devoid of conven-
tional AP-1 or meAP-1 sites. Both sets of promoters served as positive
and negative controls, respectively. Ten promoters that were found to
contain meAP-1 sites (and lack conventional AP-1 sites in proximity)
were analyzed by ChIP and the results are shown in green. The PSMC1
promoter contains two separate regions with one meAP-1 site each
depicted as PSMC1-1 and -2, which were analyzed separately. Details
of all promoters investigated here are listed in Table 1. Means and
standard deviations of three independent experiments are shown.
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one strand of the AP-1 consensus motif providing similar
molecular structures for AP-1 binding (Figures 2C and 6).
The structural resemblance of thymine to
50-methylcytosine suggests that the c-Jun/c-Fos
heterodimer binds similarly to AP-1 and meAP-1 sites
(39,44). As c-Jun/c-Fos heterodimers target meAP-1 sites
in vivo (Figures 3 and 5, Supplementary Figures S5 and
S7), the status of DNA methylation determines AP-1
binding and consequently responsiveness to AP-1-
mediated transcriptional activation. In this context,
DNA methylation adds a new layer to gene regulation
and presumably also cell type- and tissue-specific function-
ality of signaling pathways that activate AP-1 family
members.
The majority of consensus AP-1 sites that were
identified in cellular chromatin are located in intergenic
regions or are distant from transcriptional start sites and
have unknown functions (31,34). We see a comparable
distribution of meAP-1 sites. Of the 45 000 potential
meAP-1 sites (Supplementary Table S9), only a small
fraction resides within 5 kb upstream of transcriptional
start sites suggesting that these meAP-1 sites might serve
an important and direct role in regulating genes that are
governed by epigenetic inhibition including DNA methy-
lation. The functions of the many consensus AP-1 and
non-canonical meAP-1 site localized in intergenic regions
remain an enigma that needs to be addressed.
Owing to the nature and frequency of potentially func-
tional meAP-1 binding sites in the cell lines and conditions
used in this study, we had to restrict our search in estab-
lished cell lines to promoters that are bound by c-Jun/
c-Fos heterodimers and contain meAP-1 sites but lack
consensus AP-1 sites in proximity for obvious technical
reasons. The strict filtering criteria resulted in a small set
of promoter candidates that likely do not reflect profound
or even decisive functions of the identified genes in human
cells. The situation is different in primary naı̈ve B cells of
human origin, in which we concentrated on meAP-1 in the
promoters of genes upregulated after induced B cell acti-
vation. The fact that AP-1 is binding these meAP-1
binding sites suggests their having functional roles in
metazoan gene regulation in certain cell types and
certain situations, e.g. during the transition from quies-
cent, resting B lymphocytes to proliferating B blasts. In
this context, c-Jun/c-Fos differs from Zta, which fre-
quently binds to many viral meZRE-containing promoters
and efficiently reverses their epigenetic repression
(5,7,14,45). These differences could be explained by the
fact that the key functions of Zta in the EBV model are
understood, whereas the c-Jun/c-Fos transcription factor
might have yet to be uncovered functional roles in differ-
ent settings. Although the functionality of the meAP-1
binding sites cannot be fully uncovered with the experi-
ments presented here, the experiments document the
in vivo existence of these elements, which are bound pref-
erentially if their DNA motif carries a 50-methylcytosine.
It is likely that these elements play a critical role in the
transcriptional activation of their target genes. These
findings now allow the investigation of other experimental
settings such as different cell lines or primary cell types as
well as distinct stimuli, stress signals or developmental
cues that activate cells, induce their immediate differenti-
ation or trigger cell fate decisions. The goal is now to
discover more examples of meAP-1 sites that regulate
the expression of critical genes to unveil the full range of
meAP-1 elements and their biological functions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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Figure 6. Sequence motifs of AP-1 and ZRE binding sites and their
molecular features. (A) Comparison of AP-1, ZRE, meAP-1 and
meZRE binding sites. The CpG pairs in the meAP-1 and meZRE
motifs are underlined. (B) Structure of the DNA bases cytosine,
50-methylcytosine and thymine. The dashed lines indicate the
hydrogen bonds with the bases of the complementary DNA strand.
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